StockNews.AI
LMAT
StockNews.AI
134 days

LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025

1. LeMaitre Vascular to release Q1 2025 results on May 1. 2. Conference call scheduled for discussing results and outlook on the same day. 3. Company specializes in devices for peripheral vascular disease treatment.

3m saved
Insight
Article

FAQ

Why Bullish?

Upcoming earnings reports often generate positive investor sentiment, especially with anticipated growth in healthcare sectors.

How important is it?

Upcoming financial results and business outlook can significantly influence LMAT's stock movement.

Why Short Term?

The impact is tied to the earnings announcement scheduled shortly, affecting immediate trading decisions.

Related Companies

MDTBIOMSYK
BURLINGTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2025 financial results on Thursday, May 1, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay through a webcast at www.lemaitre.com/investor. About LeMaitre LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com. LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.

Related News